Identification of Darunavir Derivatives for Inhibition of SARS-CoV-2 3CL(pro)

The effective antiviral agents that treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are urgently needed around the world. The 3C-like protease (3CL(pro)) of SARS-CoV-2 plays a pivotal role in virus replication; it also has become an important therapeutic target for the infection o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ling, Xie, Yongli, Zhu, Mei, Yi, Dongrong, Zhao, Jianyuan, Guo, Saisai, Zhang, Yongxin, Wang, Jing, Li, Quanjie, Wang, Yucheng, Cen, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781983/
https://www.ncbi.nlm.nih.gov/pubmed/36555652
http://dx.doi.org/10.3390/ijms232416011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781983/
https://www.ncbi.nlm.nih.gov/pubmed/36555652
http://dx.doi.org/10.3390/ijms232416011

Ejemplares similares